Nina Shah, MD #HemeWorkshop2020
5:16
Nina Shah talks about differences in tumor microenvironment populations and how stimulatory/inhibotory factors can influence how patients respond to immunotherapy, and new BCMA-targeted therapies for myeloma on the horizon.
Nina Shah talks about differences in tumor microenvironment populations and how stimulatory/inhibotory factors can influence how patients respond to immunotherapy, and new BCMA-targeted therapies for myeloma on the horizon.